Cancer news and cancer widget

MONTEREY, CA, USA (UroToday.com) - In his State-of-the-Art talk, Colin Collins discussed biomarkers for prostate cancer (CaP) risk stratification. He asked where genome copy number profiles can predict CaP recurrences. To explore this, his group used array comparative genomic hybridization (CGH) to identify genes mutations. The array data displays gene amplification and losses as topographical data.

MONTEREY, CA, USA (UroToday.com) - A State-of-the-Art lecture by Erik Castle addressed the question of whether robotic cystectomy was ready for "prime time." Prime time was defined as an operation that is equivalent to open surgery, reasonable, reproducible, and teachable. Is it equivalent to open cystectomy? He discussed the oncologic outcome of lymph node count, which improved with experience in his series from 11 in the first 10 cases to 21 in the last 10 cases.

MONTEREY, CA, USA (UroToday.com) - In this session, Christopher P. Evans presented a State-of-the-Art lecture on molecular targets in prostate and renal cancers. Molecular targets in cancer diagnosis and therapy have come to the fore of the oncology field in the last decade. Their identification is rooted in basic science investigation and enhanced knowledge in the fields of genetics, biochemistry, molecular and tumor biology, and pathology, among others.

HealthDay - SUNDAY, Nov. 2 (HealthDay News) -- Obesity can wreck a person's health for many reasons. But for women, too much weight tacks on an additional danger: Studies have linked obesity and breast cancer in a variety of ways.

(University of Bonn) By playing it safe and using a two-pronged attack, a novel designer molecule fights malignant melanoma. It was created and tested by an international team of researchers led by the University of Bonn. In Nature medicine's November issue they report about this promising strategy.

(Rockefeller University) Scientists have developed a genome-wide platform to study how specialized proteins regulate RNA in living, intact cells. The platform allows researchers to identify, in a single experiment, every sequence within every strand of RNA to which proteins bind. The result is an unbiased and unprecedented look at how differences in RNA can explain how a worm and a human can each have 25,000 genes yet be so different.

AFP - Scientists in the United States have created super-charged immune cells that helped beat back cancer tumours in half of a small group of patients tested, according to a study released Sunday.

A study of nearly 1,500 patients treated for kidney cancer at UCLA in the last 15 years shows that an aggressive, tailored treatment approach results in better survival rates and uncovered subsets of kidney cancer that behave differently and need to be treated accordingly.